Results 1 to 10 of about 45,639 (116)

Self-reported cannabis use to manage opioid withdrawal symptoms and reductions in opioid use among people who use unregulated opioids: a cross-sectional analysis [PDF]

Journal of Cannabis Research
Background Opioid withdrawal is a significant challenge for people seeking to reduce or eliminate opioid use, and unmanaged withdrawal increases the risk of relapse and overdose.
Erica McAdam, Hudson Reddon, M Eugenia Socías, Stephanie Lake, Kanna Hayashi, Kora DeBeck, Zach Walsh, M-J Milloy   +7 more
doaj   +2 more sources

Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence

Frontiers in Pharmacology, 2023
Opioid use disorder is characterized by excessive use of opioids, inability to control its use, a withdrawal syndrome upon discontinuation of opioids, and long-term likelihood of relapse.
Gary B. Kaplan, Gary B. Kaplan, Gary B. Kaplan, Benjamin L. Thompson   +3 more
doaj   +3 more sources

Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS)

Heliyon, 2021
As the opioid epidemic continues to grow, opioid use among pregnant women is increasing significantly. This has led to a steady rise in the number of infants born with neonatal opioid withdrawal syndrome (NOWS).
Sarah Stevens, Shekher Mohan
doaj   +3 more sources

Outpatient-based buprenorphine-assisted opioid withdrawal management: A preliminary prospective observational study [PDF]

Indian Journal of Psychiatry
Background: Indian guidelines mention the use of buprenorphine in opioid withdrawal in both outpatient and inpatient setting. Aim: This is the first study aiming at assessing the feasibility aspects of outpatient-based buprenorphine-assisted opioid ...
Avinash Jhajharia, Priyanka Saha, Piyali Mandal, Atul Ambekar   +3 more
doaj   +2 more sources

Concurrent opioid and alcohol withdrawal management [PDF]

Mental Health Clinician, 2023
Concurrent alcohol and opioid withdrawal syndrome is a common and challenging clinical scenario with little published evidence or guidance to inform pharmacotherapy strategies.
Michelle Colvard, PharmD, BCPP
doaj   +1 more source

Implementation of a clinical pathway to screen and treat medical inpatients for opioid withdrawal

Implementation Research and Practice, 2022
Background: Opioid-related inpatient hospital stays are increasing at alarming rates. Unidentified and poorly treated opioid withdrawal may be associated with inpatients leaving against medical advice and increased health care utilization.
Kimberly D. Williams, Beverly L. Wilson, Claudine T. Jurkovitz, Jo A. Melson, Jeffrey A. Reitz, Carmen K. Pal, Sherry P. Hausman, Erin Booker, Linda J. Lang, Terry L. Horton   +9 more
doaj   +1 more source

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine [version 2; peer review: 2 approved]

F1000Research, 2023
Background: Buprenorphine, a partial agonist of the mu-opioid receptor, is an increasingly prescribed medication for maintenance treatment of opioid use disorder.
Alison Lynch, Antony Gout, Vicki Kijewski, Nicholas L. Bormann   +3 more
doaj   +1 more source

Opioid Withdrawal Produces Sex-Specific Effects on Fentanyl-Versus-Food Choice and Mesolimbic Transcription

Biological Psychiatry Global Open Science, 2021
Background: Opioid withdrawal is a key driver of opioid addiction and an obstacle to recovery. However, withdrawal effects on opioid reinforcement and mesolimbic neuroadaptation are understudied, and the role of sex is largely unknown. Methods: Male (n =
E. Andrew Townsend, R. Kijoon Kim, Hannah L. Robinson, Samuel A. Marsh, Matthew L. Banks, Peter J. Hamilton   +5 more
doaj   +1 more source

Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule

Addiction Science & Clinical Practice, 2021
Background In the United States, methadone for opioid use disorder (OUD) is limited to highly regulated opioid treatment programs (OTPs), rendering it inaccessible to many patients.
Jordana Laks, Jessica Kehoe, Natalija M. Farrell, Miriam Komaromy, Jonathan Kolodziej, Alexander Y. Walley, Jessica L. Taylor   +6 more
doaj   +1 more source

The past, present and future of opioid withdrawal assessment: a scoping review of scales and technologies

BMC Medical Informatics and Decision Making, 2019
Background A common challenge with all opioid use disorder treatment paths is withdrawal management. When withdrawal symptoms are not effectively monitored and managed, they lead to relapse which often leads to deadly overdose.
Joseph K. Nuamah, Farzan Sasangohar, Madhav Erraguntla, Ranjana K. Mehta   +3 more
doaj   +1 more source